Bonus Biogroup Ltd. is a biotechnology company, which engages in the field of stem cells and tissue engineering. The firm is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. The company is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.
BBIXF stock price ended at $0.15 on Çarşamba, after rising 50.00%
On the latest trading day Feb 11, 2026, the stock price of BBIXF rose by 50.00%, climbing from $0.15 to $0.15. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.15 and a high of $0.15. Alongside this price increase, trading volume also rose by 17.5K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 500 shares were traded, amounting to a market value of approximately $175.1M.
BBIXFTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 4
Nötr Sinyaller 1
Satış Sinyalleri 2
Strong Sell
Sell
Neutral
Buy
Strong Buy
BBIXF, şu anda 4 alım sinyali ve 2 satım sinyali vermektedir. Hisse senedi 12:00 AM'ten beri Yukarı trend durumundadır ve bu dönemde toplam 66.67% fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Buy görünüm işaret etmektedir.
BBIXF için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek BBIXF için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.